Page last updated: 2024-11-04

scriptaid and Amyotrophic Lateral Sclerosis

scriptaid has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

scriptide: provokes translocation of GLUT4 to increase glucose uptake; structure in first source

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corcoran, LJ1
Mitchison, TJ1
Liu, Q1

Other Studies

1 other study available for scriptaid and Amyotrophic Lateral Sclerosis

ArticleYear
A novel action of histone deacetylase inhibitors in a protein aggresome disease model.
    Current biology : CB, 2004, Mar-23, Volume: 14, Issue:6

    Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Fractionation; Chlorocebus aethiops; COS Cells; Disease

2004